Correlation Between Hillstream Biopharma and Sonnet Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Hillstream Biopharma and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hillstream Biopharma and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hillstream Biopharma and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Hillstream Biopharma and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hillstream Biopharma with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hillstream Biopharma and Sonnet Biotherapeutics.

Diversification Opportunities for Hillstream Biopharma and Sonnet Biotherapeutics

0.0

Correlation Coefficient

Hillstream Biopharma  Sonnet Biotherapeutics

Pay attention - limited upside

The 3 months correlation between Hillstream and Sonnet is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Hillstream Biopharma and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Hillstream Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hillstream Biopharma are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Hillstream Biopharma i.e., Hillstream Biopharma and Sonnet Biotherapeutics go up and down completely randomly.

Pair Corralation between Hillstream Biopharma and Sonnet Biotherapeutics

If you would invest  144.00  in Sonnet Biotherapeutics Holdings on December 21, 2024 and sell it today you would lose (1.00) from holding Sonnet Biotherapeutics Holdings or give up 0.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Hillstream Biopharma  vs.  Sonnet Biotherapeutics Holding

Hillstream Biopharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Hillstream Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Hillstream Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Sonnet Biotherapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sonnet Biotherapeutics Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Sonnet Biotherapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Hillstream Biopharma and Sonnet Biotherapeutics

The main advantage of trading using opposite Hillstream Biopharma and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hillstream Biopharma position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.

The idea behind Hillstream Biopharma and Sonnet Biotherapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.